Simultaneous Quantification of Naproxcinod and Its Active Metabolite Naproxen in Rat Plasma Using LC-MS/MS: Application to a Pharmacokinetic Study.

Xiaowei Shi,Weiding Shang,Shuang Wang,Na Xue,Yanxia Hao,Yabo Wang,Mengmeng Sun,Yumin Du,Deying Cao,Kai Zhang,Qingwen Shi
DOI: https://doi.org/10.1016/j.jchromb.2014.12.001
IF: 3.318
2015-01-01
Journal of Chromatography B
Abstract:In this study, a liquid chromatography-tandem mass spectrometry method was developed and validated to simultaneously determine naproxcinod and naproxen concentrations in rat plasma for the first time. Plasma samples were prepared by simple one-step extraction with methanol for protein precipitation using only 50 mu L plasma. Separation was performed on a Synergi Fusion-RP C18 column with a run time of 4 min. Naproxcinod, naproxen and internal standard concentrations were detected in the positive ion mode using multiple reaction monitoring (MRM) of the transitions at m/z 348.2 -> 302.2, 231.1 -> 185.1 and 271.2 -> 203.1, respectively. The calibration curves were linear, with all correlation coefficients being >= 0.9952, in the range of 1.00-400 ng/mL for naproxcinod and 20.0-8000 ng/mL for naproxen. Their accuracy was in the range of -8.1% to 8.7%, and the intra- and inter-day variations were <= 4.53%. The mean extraction recovery of all analytes was more than 93.1% efficient. Stability testing showed that naproxcinod and naproxen remained stable during the whole analytical procedure. After validation, the method was successfully applied to a pharmacokinetic study of naproxcinod and naproxen in rats. The AUC(0-infinity) of naproxen was 74.6 times larger than that of naproxcinod, which indicated that naproxcinod was rapidly metabolized into naproxen in rats. (C) 2014 Elsevier B.V. All rights reserved.
What problem does this paper attempt to address?